Skip to content
Abilene News

Experimental Lilly drug tops Ozempic in weight loss study

Experimental Lilly drug tops Ozempic in weight loss study
Photo: KTXS (ABC 12) Abilene News · view original

A new late-stage study suggests Eli Lilly’s experimental weekly injection retatrutide may help adults with Type 2 diabetes lose more weight than Ozempic.

Sources and story details